Lungcancer:diagnosisandmanagementLungcancer:diagnosisandmanagement NICEguideline Published:28March2019 nice.uk/guidance/ng122 ©NICE2019.Allrightsreserved.SubjecttoNoticeofrights(https://.nice.uk/terms-and-conditions#notice-of- rights). http://guide.medlive/...
Monumental, evidence based, but not "less is more"It is difficult to recall the 1990s, when patients in the United Kingdom with suspected cancer sometimes waited months for investigation. In 2000 the Department of Health introduced guidelines for referral, structured pathways, and a waiting time ...
see NICE''s guidelines on cardiovascular disease: identifying and supporting people most at risk of dying early, type 1 diabetes in adults, asthma and chronic obstructive pulmonary disease) ? people with a smoking-related illness (see NICE''s guideline on lung cancer) Tobacco: preventing uptake,...
These developments provided the impetus to re-evaluate and restructure brain tumour service provision for the Anglian Cancer Network. The existing patient pathway of care was mapped to define the pattern of referrals to the neurosurgical service and to identify how this could be changed to facilitate...
This is the first example of a green light being given under NICE's early value assessment (EVA) pathway for medtech innovations, which was piloted with five apps for mild anxiety last year and aims to provide quicker access to digital health products, diagnostics, and devices that could reli...
Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia? Background: Recent guidelines from NICE have proposed that open access gastroscopy is largely limited to patients with alarm symptoms. Aims and methods: Th... N Sundar,V Muraleedharan,J Pandit,... - 《...
Implementation of NICE guidelines on the recognition and initial management of ovarian cancer The clinical telephone helpline discussed here is a communication channel for family members and caregivers whose loved ones are in hospital. It makes full... DB Nice 被引量: 0发表: 2014年 ...
This study has attempted to assess the effectiveness of quantitative faecal immunochemical tests (FIT) for triage of people presenting with lower abdominal symptoms, where a referral to secondary care for investigation of suspected colorectal cancer (CRC) is being considered, particularly when the 2-we...
NICE referral guidelines for suspected cancer: colorectal cancer and faecal occult blood testing. Ann Clin Biochem. 2016;53(1):7–9. Article CAS PubMed Google Scholar Fraser CG, Strachan JA. A nicer approach to the use of 'faecal occult blood tests' in assessment of the symptomatic. Ann ...
Regorafenib for Liver Cancer NICE gave a positive assessment of regorafenib (Stivarga, Bayer) as an option for treating advanced unresectable hepatocellular carcinoma in adults who have had sorafenib (Nexavar, Bayer). Infinal guidance, it said regorafenib was a possible treatment option for patients ...